A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans

Viral Immunology

Volumn 11, Issue 3, 1998, Pages 147-158

  Nehete, Pramod N ^a   Schapiro, Steven J ^a   Johnson, Philip C ^b   Murthy, Krishna K ^c   Satterfield, William C ^a   Sastry, K Jagannadha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 160; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CHIMPANZEE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; T LYMPHOCYTE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MURINAE; PAN (APE); PAN TROGLODYTES; RNA VIRUSES;

EID: 0032415547     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.147     Document Type: Article

References (31)

1. Bjorling, E. and E. Norrby. 1996. B-cell sites in the HIV glycoproteins. p 57-78. In; Immunology of HIV Infection. Edited by S. Gupta. Plenum Medical Book Company, New York.
2. Boucher, C.A.B., J.M.A. Lange, F. Miedema, G.J. Weverling, M. Koot, J.W. Mulder, J. Goudsmit, P. Kellam, B.A. Larder, and M. Tersmette. 1992. HIV-1 biological phenotype and development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 6:1259-1264.
3. Clerget-Raslain, B., A. Benjouad, J. Van Rietschoten, L. Montagnier, H. Rochat, and E. Bahraoui. 1991. Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIVl envelope glycoprotein. Res. Virol. 142:423-438.
4. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, and G.M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1892-1899.
5. Clerici, M., J.A. Berzofsky, G.M. Shearer, and C.O. Tacket. 1991. Exposure to human immunodeficiency virus type 1-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J. Infect. Dis. 164:178-182.
6. Dadaglio, G., A. Leroux, P. Langlade-Demoyen, E.M. Bahraoui, F. Traincard, R. Fisher, and F. Plata. 1991. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J. Immunol. 147:2302-2309.
7. Dai, L.C., K. West, R. Littaua, K. Takahashi, and F.A. Ennis. 1992. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A 24-restricted cytotoxic T lymphocytes. J. Virol. 66:3151-3154.
8. Dupuis, M., S.K. Kundu, and T.C. Merigan. 1995. Characterization of HLA-A*0201-restricted cytotoxic T-cell epitopes in conserved regions of the HIV type 1 gp160 protein. J. Immunol. 155:2232-2239.
9. Eichberg, J.W., J.M. Zarling, H.J. Alter, J.A. Levy, P.W. Berman, T. Gregory, L.A. Lasky, J. McClure, K.E. Cobb, P.A. Moran, S.L. Hu, R.C. Kennedy, T.C. Chanh, and G.R. Dressman. 1987. T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. J. Virol. 61:3804-3808.
10. Gruters, R.A., F.G. Tepstra, J.M. Lange, M.T. Roos, T. Harkema, J.W. Mulder, F. DeWolf, P.T. Schellekens, and F. Miedema. 1991. Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake. AIDS 5:43-47.
11. Heeney, J., R. Jonker, W. Koornstra, R. Dubbes, H. Niphuis, A.M. Rienzo, M.L. Gougeon, and L. Montagnier. 1993. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J. Med. Primatol. 22:194-200.
12. Houghten, R.A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82:5131-5135.
13. Jassoy, C., R.P. Johnson, B.A. Navia, J. Worth, and B.D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
14. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T-cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: Definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
15. Koot, M., P.T.A. Schellekens, J.W. Mulder, J.M. Lange, M.T. Roos, R.A. Coutinho, M. Tersmette, and F. Miedema. 1993. Viral phenotype and T-cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine. J. Infect. Dis. 168:733-736.
16. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
17. Merrifield, R.B. 1963. Solid phase peptide synthesis. J. Am. Chem. Soc. 85:2149-2154.
18. Modrow, S., B.H. Hahn, G.M. Shaw, R.C. Gallo, F. Wong-Staal, and H. Wolf. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:570-578.
19. Nehete, P.N., W.C. Satterfield, C.M. Matheme, R.B. Arlinghaus, and K.J. Sastry. 1993. Induction of human immunodeficiency virus-specific T-cell responses in Rhesus monkeys by synthetic peptides from gp160. AIDS Res. Hum. Retroviruses 9:235-240.
20. Nehete, P.N., K.K. Murthy, W.C. Satterfield, R.B. Arlinghaus, and K.J. Sastry. 1995. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1 IIIB. AIDS 9:567-572.
21. Nehete, P.N., P.C. Johnson, S.J. Schapiro, R.B. Arlinghaus, and K.J. Sastry. 1996. Cross-reactive T-cell prolifer-ative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals. J. Clin. Immunol. 16:115-124.
22. Picard, O., A. Achour, J. Bernard, A. Halbreich, B. Bizzini, V. Boyer, C. Desgranges, J.M. Bertho, A. Lachgar, B. Polliotti, M.C. Defere, K. Lanneval, J.C. Imbert, J. Frottier, J.J. Salaun, A. Burny, and D. Zagury. 1992. A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: Evidence for persistent cell-mediated immunity. J. Acquir. Immune. Defic. Syndr. 5:539-546.
23. Pontesilli, O., M. Carlesimo, A.R. Varani, R. Ferrara, E.G. Guerra, M.L. Bernardi, G. Ricci, A.M. Mazzone, G. D'Offizi, and F. Aiuti. 1995. HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. Clin. Exp. Immunol. 100:419-424.
24. Rinaldo, C., X-Li Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J. Virol. 69:5838-5842.
25. Roos, M.T.L., F. Miedema, M. Koot, M. Tersmette, W.P. Schaasberg, R.A. Coutinho, and P.T.A. Schellekens. 1995. T-cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 171:531-536.
26. Rosenberg, E.S., J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker. 1997. Vigorous HIV-1 specific CD4 T cell responses associated with control of viremia. Science 278:1447-1450.
27. Rowland-Jones, S.L., D.F. Nixon, M.C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J.S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet 341:860-861.
28. Rowland-Jones, S.L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59-64.
29. Sastry, K.J., and R.B. Arlinghaus. 1991. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV env protein. AIDS 5:699-707.
30. Schellekens, P.T.A., M.T.L. Roos, F. De Wolf, J.M.A. Lange, and F. Miedema. 1990. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human im-munodeficiency virus-1 (HIV-1)-infected men. J. Clin. Immunol. 10:121-127.
31. Schrier, R.D., J.W. Gnann, R. Landes, C. Lockshin, D. Richman, A. McCutchan, C. Kennedy, M.B. Oldstone, and J.A. Nelson. 1989. T cell recognition of HIV synthetic peptides in natural infection. J. Immunol. 142:1166-1176.